Omeprazole- 13 C,d 3

Overview

Omeprazole- 13 C,d 3 is a 13 C-labeled and deuterium labeled Omeprazole. Omeprazole (H 16868) is an orally active H + ,K + -ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19 , CYP3A4 , and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis , autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Research Areas > Metabolic Disease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Na+/K+ ATPase | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > Proton Pump | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > Atg8/LC3 | Products > Signaling Pathways > Isotope-Labeled Compounds

Product Information

• Catalog No.: HY-B0113S3
• CAS No.: 1261395-28-1
• Molecular Formula: C1613CH16D3N3O3S
• Molecular Weight: 349.43
• Purity: 98.00%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source